Correlation Between Hypera SA and Emergent Biosolutions
Can any of the company-specific risk be diversified away by investing in both Hypera SA and Emergent Biosolutions at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Hypera SA and Emergent Biosolutions into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Hypera SA and Emergent Biosolutions, you can compare the effects of market volatilities on Hypera SA and Emergent Biosolutions and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Hypera SA with a short position of Emergent Biosolutions. Check out your portfolio center. Please also check ongoing floating volatility patterns of Hypera SA and Emergent Biosolutions.
Diversification Opportunities for Hypera SA and Emergent Biosolutions
-0.46 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Hypera and Emergent is -0.46. Overlapping area represents the amount of risk that can be diversified away by holding Hypera SA and Emergent Biosolutions in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Emergent Biosolutions and Hypera SA is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Hypera SA are associated (or correlated) with Emergent Biosolutions. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Emergent Biosolutions has no effect on the direction of Hypera SA i.e., Hypera SA and Emergent Biosolutions go up and down completely randomly.
Pair Corralation between Hypera SA and Emergent Biosolutions
Assuming the 90 days horizon Hypera SA is expected to under-perform the Emergent Biosolutions. But the pink sheet apears to be less risky and, when comparing its historical volatility, Hypera SA is 4.05 times less risky than Emergent Biosolutions. The pink sheet trades about -0.09 of its potential returns per unit of risk. The Emergent Biosolutions is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest 257.00 in Emergent Biosolutions on August 29, 2024 and sell it today you would earn a total of 746.00 from holding Emergent Biosolutions or generate 290.27% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Hypera SA vs. Emergent Biosolutions
Performance |
| Timeline |
| Hypera SA |
| Emergent Biosolutions |
Hypera SA and Emergent Biosolutions Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Hypera SA and Emergent Biosolutions
The main advantage of trading using opposite Hypera SA and Emergent Biosolutions positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Hypera SA position performs unexpectedly, Emergent Biosolutions can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Emergent Biosolutions will offset losses from the drop in Emergent Biosolutions' long position.The idea behind Hypera SA and Emergent Biosolutions pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| Emergent Biosolutions vs. Zoetis Inc | Emergent Biosolutions vs. Bausch Health Companies | Emergent Biosolutions vs. Neurocrine Biosciences | Emergent Biosolutions vs. Akanda Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Other Complementary Tools
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |